Top-Line Summary: REDEFINE 4 (CagriSema vs Tirzepatide) - - - CagriSema: 23.0% weight loss (efficacy estimand) Tirzepatide: 25.5% weight loss Treatment-regimen estimand: CagriSema 20.2% Tirzepatide 23.6% Primary endpoint: Not met (non-inferiority) Safety: Mostly GI AEs, consistent with class Perspective: A therapy producing ~23% weight loss is framed as missing. Thats how far obesity pharmacotherapy has progressed
Ready to find out what fits your budget
The concern about hair loss while using semaglutide has been raised by some patients, though it is not listed as one of the most common side effects
Resistance training: the non-negotiable signal Your muscles need a reason to stick around
Conclusion BPC-157 is a synthetic 15-amino-acid peptide that continues to attract attention within peptide research
May ease cramping, bloating, gas, constipation These little enzyme capsules may help ease common digestive symptoms from tough-to-digest foods, like cramping, bloating, gas and occasional constipation.* Here's how
